Table 2

Patients and families with mutations in the converter region from the bibliography

MutationN FamiliesN PatientsN CarriersDiagnosisCardiovascular death or transplantReferences
(see online supplementary file A)
HCMDCMRCMLVNCSDUCNASDHTXStrokeHFOtherTotal
Arg712Leu1654111000011
Gly716Arg1546332622214172150252–7 15 18 19 21 23 27 34
Arg719Gln30583050701295031388–30 96
Arg719Trp2690808114222110412718 19 23 25 30–47 81
Arg721Lys1220200010148
Arg723Cys82020141500000023 46 49–59 96
Arg723Gly8777566524741802060–67
Arg723His111100000068
Ala728Val176730000369
Pro731Leu24221130000370–88
Gly733Glu49971110000123 72 73
Gly733Arg1110100000071
Gln734Glu111100000074–76
Ile736Met222200000077 78 88 94 95
Ile736Thr102424182400000016 37 64 79 81–96 94–96
Gly741Arg910101000000015 23 24 27 80 87–90
Gly741Trp628282800000021 88 91–95
Ala742Glu111100000096
Val763Gly1221100000084
Val763Met111100000021
Phe764Leu14303110000174 97 98
Gly768Arg5151411110211010316 18 19 23 80 99–100
Total13540935033113533252084132222123
  • CVA, death related to cerebrovascular accident; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; HF, heart failure related death; HTX, heart transplantation; LVNC, LV non-compaction; NA, not clinically affected; Other, other cardiovascular cause of death; RCM, restrictive cardiomyopathy; SD, sudden death without diagnosis; UC, unspecified cardiomyopathy.